RARA CRAFT DATABASE for FDA Medical Devices
510(k)K222482

FDA DEVICE FACTS

AGILON XO Shoulder System

Implantcast GmbH

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATESeptember 28, 2022PRODUCT CODEKWT

Indications for use

The AGILON@ XO Shoulder Replacement System is indicated for use for total or hemi shoulder replacement in cases of: * Non- inflammatory degenerative joint disease including osteoarthritis and avascular necrosis, * Post-traumatic osteoarthritis, * Fractures, * Rheumatoid arthritis. The main indications for the implantation of an AGILON@ hemi shoulder prosthesis are: * Multifragmental comminuted fractures of the humeral head, * 3- and 4-Fragment-fractures of the proximal humerus, * Head-splitting fractures, * Dislocated head-splitting fractures, * Humeral head depression with more than 40% ofjoint surface depressed, * Interlocking chronic dislocation with deep HILL-SACHS lesion, * Fracture instability following internal fixation attempt in 3-fragment and 4-fragment fractures (secondary dislocation, material loosening), * Posttraumatic humeral head necrosis, * Omarthrosis. AGILON@ CTA heads are destined for treatment of stable types of rotator cuff tear arthropathy. In order to achieve satisfactory results with the CTA heads the fornix humeri and the subscapularis tendon must be intact. A CTA cap is intended for the use as a hemi-arthroplasty to treat a patient in revision cases after an inverse shoulder has failed. It is not combined with a glenoid implant. It can also be used in primary cases. The main indications for the implantation of an AGILON@ inverse (reverse) shoulder prosthesis are: * Rotator cufftear arthropathy, * Chronic trauma shoulder, * Decentering of the humeral head after implantation of a humeral head prosthesis. Please note, that the patient's joint must be anatomically and structurally suited to receive the selected implant(s), and a functional deltoid muscle is necessary. AGILON@ retentive caps invers are indicated in case of shoulder joint instability if the joint cannot be stabilized with a regular AGILON@ cap inverse in combination with a Glenosphere. Warning: The use of the AGILON@ retentive caps invers entails a decrease of the Range of Motion of the prosthesis. The surgeon has to balance conscientiously the advantage of stabilization and the increased risk of scapula impingement. In case of revision surgery the available bone stock has to be evaluated to allow for implantation of well-fixed stems. Conversion of the system can be performed in revision cases as follows: * From Hemi Shoulder Arthroplasty to Anatomic Total Shoulder Arthroplasty * From Hemi Shoulder Arthroplasty to Hemi CTA Shoulder Arthroplasty * From Hemi Shoulder Arthroplasty to Inverse (Reverse) Total Shoulder Arthroplasty * From Inverse (Reverse) Total Shoulder Arthroplasty to Hemi Shoulder Arthroplasty as salvage procedure * From Inverse (Reverse) Total Shoulder Arthroplasty to Hemi CTA Shoulder Arthroplasty as salvage procedure * From Anatomic Total Shoulder Arthroplasty to Inverse (Reverse) Total Shoulder Arthroplasty * From Anatomic Total Shoulder Arthroplasty to Hemi CTA Shoulder Arthroplasty The surgeon decides which version of prosthesis for the individual patient is used. This decision depends on several factors, such as the age and the patient's weight, bone quality, shape of the bone and deformation of the joint. The device is intended for adults. The stems of the AGILON@ XO Shoulder Replacement System are intended for cementless fixation. The glenoids of the AGILON@ XO Shoulder Replacement System are intended for cemented fixation.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 22, 2026